Ruthenium-based complex catalysts
US-2015057450-A1 · Feb 26, 2015 · US
US9802972B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9802972-B2 |
| Application number | US-201414896412-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2014 |
| Priority date | Jun 9, 2013 |
| Publication date | Oct 31, 2017 |
| Grant date | Oct 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides novel ruthenium or osmium based complex structures with a unique combination of ligands comprising a Schiff-base type ligand, a N-heterocyclic carbene ligand and a CO ligand which can be prepared according to two different routes involving easily accessible starting materials and which represent excellent catalysts for hydrogenating unsaturated compounds, oligomers and polymers, in particular at unforeseeably low temperatures.
Opening claim text (preview).
The invention claimed is: 1. A complex having the general formula (I) wherein: M is ruthenium or osmium; Y represents H, F, Cl, Br, I, CF 3 , pyridine, —OC 6 H 5 , CF 3 COO—, CH 3 SO 3 —, or BF 4 ; R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; CF 3 ; halogen; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents; or OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or (N(R 8 ) 3 ) + X − wherein X is halide, and R 8 are identical or different and represent H; straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl, substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents; or tris (C 1 -C 6 -alkoxy)silyl-C 1 -C 6 -alkyl, tris (C 6 -C 14 -aryloxy)silyl-C 1 -C 6 -alkyl, or tris(C 3 -C 10 -cycloalkoxy)silyl-C 1 -C 6 -alkyl; R 5 represents H; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents. 2. The complex of general formula (I) according to claim 1 , wherein: M is ruthenium; Y is H or Cl; R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; F, Cl, or Br; or straight chain or branched, substituted or unsubstituted C 1 -C 8 -alkyl; or substituted or unsubstituted C 5 -C 8 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; or OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; R 5 represents H; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents. 3. The complex of general formula (I) according to claim 1 , wherein: M is ruthenium, Y is H or Cl, R 1 , R 2 , R 3 , and R 4 are all H or R 1 , R 3 , and R 4 are all H while R 2 is simultaneously NO 2 ; R 5 represents H; straight chain or branched, substituted or unsubstituted C 1 -C 8 -alkyl; or substituted or unsubstituted C 5 -C 8 -cycloalkyl; or substituted or unsubstituted C 6 -C 10 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents. 4. The complex of the general formula (I) according to claim 1 , wherein the N-heterocyclic carbene ligand comprises a cyclic carbene type ligand based on imidazoline or imidazolidine moieties and having at least one nitrogen as hetero atom present in the ring. 5. The complex according to claim 4 , wherein, in the N-heterocyclic carbene ligand in the complex of the general formula (I), R 6 and R 9 are identical or different and represent hydrogen, C 6 -C 24 -aryl, or form a cycloalkyl or aryl structure together with the carbon atoms to which they are bound, and R 10 and R 11 are identical or different represent straight-chain or branched C 1 -C 10 -alkyl, C 3 -C 10 -cycloalkyl, substituted or unsubstituted C 6 -C 24 -aryl, 2,6-diisopropylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, C 1 -C 10 -alkylsulfonate, or C 6 -C 10 -arylsulfonate. 6. The complex according to claim 1 , wherein the N-heterocyclic carbene ligand in the complex of the general formula (I) has the structures (IIIa) to (IIIu), where “Ph” means in each case phenyl, “Bu” means in each case butyl, “Mes” represents in each case 2,4,6-trimethylphenyl, “Dipp” means in all cases 2,6-diisopropylphenyl, and “Dimp” means in each case 2,6-dimethylphenyl 7. The complex according to claim 1 , wherein the complex of general formula (I) is selected from the group consisting of (Ia)-IMes, (Ia)-SIMes, (Ia)-IPr, (Ib)-IMes, (Ib)-SIMes, (Ib)-IPr, (Ic)-IMes, (Ic)-SIMes, (Ic)-IPr, wherein “IMes” means N,N′-bis(mesityl)imidazol-2-ylidene, “SIMes” means N,N′-bis(mesityl)imidazolidin-2-ylidene, “IPR” means N,N′-bis(2,6-diisopropyl-phenyl)imidazol-2-ylidene and “ItBu” means N,N′-bis(tert-butyl)imidazol-2-ylidene, 8. A process for preparing the complex of general formula (I) according to claim 1 , the process comprising: reacting a compound of general formula (1) MXY(CO)(PR 3 ) n (1) wherein: M is ruthenium or osmium; X is H, Cl, Br or I; Y represents H, F, Cl, Br, I, CF 3 , pyridine, —OC 6 H 5 , CF 3 COO—, CH 3 SO 3 —, or BF 4 ; R represents substituted or unsubstituted C 1 -C 14 -alkyl; substituted or unsubstituted C 3 -C 8 -cycloalkyl; substituted or unsubstituted C 6 -C 14 -aryl; and n is 3, if R represent substituted or unsubstituted C 6 -C 14 -aryl; or n is 2, if R represent substituted or unsubstituted C 1 -C 14 -alkyl, or substituted or unsubstituted C 3 -C 8 -cycloalkyl; with a compound of general formula (2) wherein R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; CF 3 ; halogen; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; substituted or unsubstituted C 3 -C 10 -cycloalkyl; substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; (N(R 8 ) 3 ) + X − wherein X is halide, and R 8 are identical or different and represent H; straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl, substituted or unsubstituted C 6 -C 14 -aryl, which aryl
At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand · CPC title
of C=C or C-C triple bonds · CPC title
Hydrogenation · CPC title
of non-aromatic carbon-to-carbon double bonds · CPC title
Ruthenium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.